Associate Professor, Medicine, Brown University Program in Medicine
Internal Medicine
Dr. Andrew Bostom, MD
|
|
Give Review
Andrew Bostom works in the field of Internal Medicine. He researched medicine at State University of New York Downstate Medical Center College of Medicine. Andrew Bostom is a published physician as well. He has 101 publications published. The latest was: Serum cystatin C as a determinant of fasting total homocysteine levels in renal transplant recipients with a normal serum creatinine.
Publications
- B-Type Natriuretic Peptide and Cardiac Troponin I Are Associated With Adverse Outcomes in Stable Kidney Transplant Recipients.
- Adiposity Patterns and the Risk for ESRD in Postmenopausal Women.
- Safety Events in Kidney Transplant Recipients: Results from the Folic Acid for Vascular Outcome Reduction in Transplant Trial.
- BP, Cardiovascular Disease, and Death in the Folic Acid for Vascular Outcome Reduction in Transplantation Trial.
- Lipoprotein levels are associated with incident hypertension in older adults.
- Type III hyperlipoproteinemia with xanthomas and multiple myeloma.
- Comparison of plasma clearance of iodixanol during versus after angiography.
- Measures of obesity are associated with vascular stiffness in young and older adults.
- Net uptake of plasma homocysteine by the rat kidney in vivo.
- Postmenopausal estrogen therapy and cardiovascular disease.
- Reduction of lipoprotein(a) following treatment with lovastatin in patients with unremitting nephrotic syndrome.
- Further characterization of the plasma lipoprotein(a) distribution.
- High homocysteine levels are independently related to isolated systolic hypertension in older adults.
- Plasma homocysteine and all-cause mortality in diabetes.
- N-acetylcysteine and lipoprotein(a)
- Extended-release niacin/laropiprant lowers serum phosphorus concentrations in patients with type 2 diabetes.
- Sustained Hypophosphatemic Effect of Once-Daily Niacin/Laropiprant in Dyslipidemic CKD Stage 3 Patients.
- Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the folic Acid for vascular outcome reduction in transp...
- Once-daily extended-release niacin lowers serum phosphorus concentrations in patients with metabolic syndrome dyslipidemia.
- New evidence for the phosphorus-lowering effects of niacin.
- Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial.
- Binder blinders-niacin of omission?
- Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial.
- Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial.
- Total plasma homocysteine and arteriosclerotic outcomes in type 2 diabetes with nephropathy.
- C-reactive protein as a predictor of total arteriosclerotic outcomes in type 2 diabetic nephropathy.
- Clinical and nutritional correlates of C-reactive protein in type 2 diabetic nephropathy.
- The effect of N-acetylcysteine on plasma total homocysteine levels in hemodialysis: a randomized, controlled study.
- Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study.
- Association between increased homocysteine levels and impaired fibrinolytic potential: potential mechanism for cardiovascular risk.
- Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of L-folinic or folic acid.
- Proteinuria as a predictor of total plasma homocysteine levels in type 2 diabetic nephropathy.
- Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels.
- Hyperhomocysteinemia in renal transplant recipients.
- B vitamins and restenosis after coronary angioplasty.
- Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour.
- Cost-effectiveness of homocysteine-lowering therapy to prevent coronary heart disease.
- Plasma total homocysteine levels among patients undergoing nocturnal versus standard hemodialysis.
- Effects of fenofibrate and gemfibrozil on plasma homocysteine.
- Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration ...
- Treatment of hyperhomocysteinemia in end-stage renal disease.
- The kidney and homocysteine metabolism.
- Serum cystatin C is an independent predictor of total homocysteine levels in stable Korean renal transplant recipients with normal serum creatinine.
- Power Shortage: clinical trials testing the "homocysteine hypothesis" against a background of folic acid-fortified cereal grain flour.
- Residual renal function and mortality risk in hemodialysis patients.
- Relationship between plasma homocysteine and vitamin status in the Framingham study population. Impact of folic acid fortification.
- The 1298A-->C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine.
- Chronic renal transplantation: a model for the hyperhomocysteinemia of renal insufficiency.
- Renal insufficiency, vitamin B(12) status, and population attributable risk for mild hyperhomocysteinemia among coronary artery disease patients in the era of folic ac...
- Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort.
- Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey.
- Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients.
- Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.
- Determinants of plasma total homocysteine levels in Korean chronic renal transplant recipients.
- Residual renal function in a large cohort of peritoneal dialysis patients: change over time, impact on mortality and nutrition.
- Cystatin C measurement: improved detection of mild decrements in glomerular filtration rate versus creatinine-based estimates?
- Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.
- Treatment of mild hyperhomocysteinemia in renal transplant recipients versus hemodialysis patients.
- Endpoints for homocysteine-lowering trials.
- Homocysteine: "expensive creatinine" or important modifiable risk factor for arteriosclerotic outcomes in renal transplant recipients?
- Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipi...
- Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine.
- Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study.
- Short-term reproducibility of total homocysteine determinations in stable renal transplant recipients.
- Determinants of fasting plasma total homocysteine levels among chronic stable renal transplant recipients.
- Prevalence of mild fasting hyperhomocysteinemia in renal transplant versus coronary artery disease patients after fortification of cereal grain flour with folic acid.
- Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women.
- The effect of folic acid fortification on plasma folate and total homocysteine concentrations.
- Homocysteine and arteriosclerosis: subclinical and clinical disease associations.
- Plasma total homocysteine and hemodialysis access thrombosis: a prospective study.
- Hyperhomocysteinemia in chronic renal disease.
- Serum cystatin C as a determinant of fasting total homocysteine levels in renal transplant recipients with a normal serum creatinine.
- Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association.
- Lower fasting total plasma homocysteine levels in stable renal transplant recipients versus maintenance dialysis patients.
- Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial.
- Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study.
- Excess prevalence of fasting and postmethionine-loading hyperhomocysteinemia in stable renal transplant recipients.
- Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes.
- Adjunctive drug therapy for acute myocardial infarction.
- Family history and premature coronary heart disease.
- Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study.
- Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients.
- High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients.
- Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study.
- Methionine loading, vitamin B6 status, and premature thromboembolic disease.
- Lack of effect of oral N-acetylcysteine on the acute dialysis-related lowering of total plasma homocysteine in hemodialysis patients.
- Relationship between plasma homocysteine, vitamin status and extracranial carotid-artery stenosis in the Framingham Study population.
- Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.
- Folic acid fortification of food.
- Renal metabolism of homocysteine in vivo.
- Microalbuminuria, lipoproteins, and diabetic control.
- Elevations in total plasma homocysteine in premature coronary artery, cerebrovascular and peripheral vascular disease.
- Lipoprotein(a) risk in women and efficacy of ascorbate.
- A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study.
- Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis.
- Validation of abbreviated oral methionine-loading test.
- Short term betaine therapy fails to lower elevated fasting total plasma homocysteine concentrations in hemodialysis patients maintained on chronic folic acid supplemen...
- High dose ascorbate supplementation fails to affect plasma homocyst(e)ine levels in patients with coronary heart disease.
- Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study.
- Lipoprotein(a) concentration and risk of atherothrombotic disease.
Schools
Suny Downstate Medical Center
Rhode Island Hospital
Doctors Specialties
- Internal Medicine
Accepted Insurances
Education
-
Brown University -
State University of New York Downstate Medical Center College of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Amanda J. Noska, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mitchell M. Levy, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Ghada Bourjeily, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Masooma A. Rehmtulla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cynthia L. Vuittonet, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronak H. Patel, MD |
|
|
Dr. Ravi Gupta, MD |
|
|
Dr. Jeffrey D. Nadelson, MD |
|
|
Dr. Rafik Jacob, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raymond O. Powrie, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert Velasco, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ujwal M. Thapa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pranith N. Perera, MD |
|
|
Dr. Yu Jin Nah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Heather Hue, MD |
|
|
Dr. Reid W. Coleman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael G. Goldstein, MD |
|
|
Dr. Jaroslaw Hepel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frederick S. Crisafulli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Natthapol Songdej, MD |